MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Amiodarone Actavis | |
New | APOHealth Pantoprazole Heartburn Relief | |
New | Atorvachol | |
New | Braftovi | |
New | Buvidal Monthly | |
New | Buvidal Weekly | |
New | Calitrol | |
New | Estrogel | |
New | Fenofibrate Mylan | |
New | Isosource 1.5 Cal | |
New | Kid Essentials | |
New | Mektovi | |
New | MycoCept | |
New | Novasource GI Forte | |
New | Nyxoid | |
New | ProNourish Digestive Balance Drink | |
New | Ralovista | |
New | Raloxifene GH | |
Revised | Aeron | Effects on Ability to Drive and Use Machines, Pharmaceutical Form, Shelf Life, Special Precautions for Storage |
Revised | Alendronate Plus D3 Sandoz | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Alphaclav Duo 500/125, Alphaclav Duo Forte 875/125 | Qualitative and Quantitative Composition |
Revised | Alphamox | Adverse Effects (Undesirable Effects) |
Revised | Amiloxyn | Product Name change, Sponsor |
Revised | Amiodarone Sandoz | TGA Date |
Revised | Anzatax | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | APO-Clarithromycin | Nature and Contents of Container |
Revised | APO-Irbesartan HCTZ | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Norfloxacin | Nature and Contents of Container, Product Name change |
Revised | APO-Omeprazole | TGA Date |
Revised | APO-Telmisartan HCTZ | Adverse Effects (Undesirable Effects), Sponsor |
Revised | APO-Tramadol | TGA Date |
Revised | APO-Zopiclone Tablets | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Atomoxetine Sandoz | Sponsor |
Revised | Atorvachol | Reinstated product, Sponsor |
Revised | Atorvastatin SZ | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Axit | List of Excipients, Qualitative and Quantitative Composition |
Revised | Azactam | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Baraclude | Pharmacological Properties |
Revised | Bemfola | Effects on Ability to Drive and Use Machines, Nature and Contents of Container |
Revised | Bicillin L-A | Adverse Effects (Undesirable Effects), New Presentation of Brand already available, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Bimatoprost Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Biological Therapies Thiamine Hydrochloride | Contraindications |
Revised | Blooms the Chemist Irbesartan HCTZ | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Cadivast | Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Chemmart Irbesartan HCTZ | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Chemmart Tramadol | TGA Date |
Revised | Chemmart Zopiclone | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Clomid | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Clozaril | Boxed Warnings, Special Warnings and Precautions for Use |
Revised | Coversyl Plus | Adverse Effects (Undesirable Effects) |
Revised | Cyproterone Sandoz | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Cyproterone Sandoz 50 mg | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Cystagon | Qualitative and Quantitative Composition |
Revised | DBL Acetylcysteine Injection Concentrate | TGA Date |
Revised | DBL Aciclovir Intravenous Infusion | Nature and Contents of Container |
Revised | DBL Amikacin Injection | TGA Date |
Revised | DBL Aminophylline Injection | TGA Date |
Revised | DBL Atracurium Besylate Injection | TGA Date |
Revised | DBL Carboplatin Injection | Sponsor, TGA Date |
Revised | DBL Cefotaxime Sodium for Injection | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | DBL Cephalothin Sodium for Injection | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | DBL Dacarbazine for Injection | TGA Date |
Revised | DBL Dexamethasone Sodium Phosphate Injection Ampoule | TGA Date |
Revised | DBL Diazepam Injection | TGA Date |
Revised | DBL Ergometrine Injection | TGA Date |
Revised | DBL Flumazenil Injection | TGA Date |
Revised | DBL Gentamicin Injection BP | TGA Date |
Revised | DBL Glyceryl Trinitrate Concentrate Injection | TGA Date |
Revised | DBL Irinotecan Injection Concentrate | Adverse Effects (Undesirable Effects), Incompatibilities, Pharmaceutical Form, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | DBL Methotrexate Injection | Boxed Warnings, Deleted Presentation, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | DBL Pethidine Hydrochloride Injection BP | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | DBL Phenytoin Injection BP | TGA Date |
Revised | DBL Sodium Phosphate and Potassium Phosphate Concentrated Injection | TGA Date |
Revised | Denpax | Effects on Ability to Drive and Use Machines |
Revised | DermAid Cream | Adverse Effects (Undesirable Effects), Contraindications, Special Warnings and Precautions for Use |
Revised | Dithiazide | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Doryx | Adverse Effects (Undesirable Effects) |
Revised | Duavive | TGA Date |
Revised | Duloxetine Sandoz | TGA Date |
Revised | Dupixent | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, New indication, New Presentation of Brand already available, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Dynastat | TGA Date |
Revised | Elelyso | Special Warnings and Precautions for Use, TGA Date |
Revised | Enbrel | Nature and Contents of Container |
Revised | Endor | TGA Date |
Revised | Endor 3.5 | TGA Date |
Revised | Entecavir Sandoz | TGA Date |
Revised | Esomeprazole SZ | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Special Warnings and Precautions for Use |
Revised | Evelyn 150/30 ED | List of Excipients |
Revised | Giotrif | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Herceptin | Adverse Effects (Undesirable Effects) |
Revised | Humira | Dose and Method of Administration, Pharmacological Properties |
Revised | Idaprex Combi 4/1.25 | Adverse Effects (Undesirable Effects) |
Revised | Indosyl Combi 4/1.25 | Adverse Effects (Undesirable Effects) |
Revised | Inflectra | TGA Date |
Revised | Intuniv | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Kadcyla | Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Kaletra | Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmaceutical Form |
Revised | Kalydeco | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Keytruda | Adverse Effects (Undesirable Effects) |
Revised | Kinson | Name of Medicine, Nature and Contents of Container |
Revised | Lisinopril Sandoz | TGA Date |
Revised | Luvox | Adverse Effects (Undesirable Effects) |
Revised | Lynparza Capsules | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties |
Revised | Lynparza Tablets | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties |
Revised | MabCampath | Adverse Effects (Undesirable Effects), Sponsor |
Revised | Mavenclad | TGA Date |
Revised | Maxor | Special Warnings and Precautions for Use |
Revised | Mayne Pharma Doxycycline Capsules | Adverse Effects (Undesirable Effects) |
Revised | Methotrexate Ebewe | Adverse Effects (Undesirable Effects), Boxed Warnings, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Metomax | List of Excipients, Nature and Contents of Container |
Revised | Mirtazapine GH | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Mirtazapine Sandoz | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Montelair | Product Name change, Sponsor |
Revised | Movox | Adverse Effects (Undesirable Effects) |
Revised | Neo-Synephrine | TGA Date |
Revised | Nexazole | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Nexium Hp7 | TGA Date |
Revised | Oralair | TGA Date |
Revised | Oralife Peppermint Lip Ointment | Product Name change |
Revised | Oxytrol | Sponsor |
Revised | Pariet | Adverse Effects, Precautions |
Revised | Pariet 10 | Adverse Effects |
Revised | Paroxetine GH | TGA Date |
Revised | Paroxetine Sandoz | Physicochemical Properties |
Revised | Paxam | TGA Date |
Revised | Paxtine | TGA Date |
Revised | Perindo Combi 4/1.25 | Adverse Effects (Undesirable Effects) |
Revised | Perindopril and Indapamide AN | Adverse Effects (Undesirable Effects) |
Revised | Perindopril and Indapamide-GH 4/1.25 | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | PiperTaz Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Plasma-Lyte 148 and 5% Glucose IV Infusion | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | Plasma-Lyte 56 and 5% Glucose IV Infusion | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Prexum Combi | Adverse Effects (Undesirable Effects) |
Revised | Promozio 250/100 | TGA Date |
Revised | Quetia | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ranitidine GH | TGA Date |
Revised | Rennie Spearmint Flavour | Contraindications, Dosage and Administration, Indications |
Revised | Resource Fruit Flavoured Beverage | Product Name change |
Revised | Revlimid | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Rithmik | TGA Date |
Revised | Rixadone | Adverse Effects, Interactions with Other Medicines, Precautions |
Revised | Rixalt | Product Name change, Sponsor |
Revised | Sandoz Ibuprofen Plus Codeine | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Sildenafil Sandoz | Nature and Contents of Container |
Revised | Solugel Wound Care Gel | Contraindications, Dosage and Administration, Indications, Sponsor |
Revised | Sovaldi | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Taltz | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Tambocor | TGA Date |
Revised | Tecentriq | Dose and Method of Administration, Pharmacological Properties |
Revised | Terry White Chemists Irbesartan HCTZ | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Terry White Chemists Tramadol | TGA Date |
Revised | Tertroxin | Sponsor |
Revised | Teveten Plus | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Tivicay | Special Warnings and Precautions for Use |
Revised | Tixol | Special Warnings and Precautions for Use |
Revised | Tobramycin AN | Special Warnings and Precautions for Use, Sponsor |
Revised | Tracleer | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Ursodox GH | TGA Date |
Revised | Valoid | TGA Date |
Revised | Venclexta | Nature and Contents of Container |
Revised | Vosevi | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | VPRIV | Adverse Effects (Undesirable Effects) |
Revised | Zimstat | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Zoton FasTabs | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Deleted | APOHealth Cold & Flu Relief Day/Night | |
Deleted | Audiclean | |
Deleted | Enalapril Actavis | |
Deleted | Herron ClearLax | |
Deleted | Intron A Redipen | |
Deleted | Irbesartan HCT Mylan | |
Deleted | Irbesartan Mylan | |
Deleted | Linezolid APOTEX | |
Deleted | Protos | |
Deleted | ReoPro | |
Deleted | Supradyn Effervescent | |
Deleted | Vaxigrip, Vaxigrip Junior |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au